Owner AEGERA Therapeutics, Inc

Inventors Durkin, Jon, P; Lacasse, Eric; McManus, Daniel

Agent Griffith Hack

Pub. Number AU-B-2003219432

PCT Number PCT/IB03/01670

PCT Pub. Number WO2003/080638

Priority 60/367,853 27.03.02 US

Filing date 27 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 1 April 2010

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/475 (2006.01) - having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides